3-methylglutaconic acid has been researched along with Basal Ganglia Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anikster, Y; Blumkin, L; Carmi, N; Kivity, S; Lerman-Sagie, T; Leshinsky-Silver, E; Lev, D; Zerem, A | 1 |
| al Aqeel, A; al Odaib, A; Brismar, J; Dabbagh, O; Gascon, GG; Ozand, PT; Rashed, M | 1 |
2 other study(ies) available for 3-methylglutaconic acid and Basal Ganglia Diseases
| Article | Year |
|---|---|
Atypical presentation of Costeff syndrome-severe psychomotor involvement and electrical status epilepticus during slow wave sleep.
Topics: Basal Ganglia Diseases; Child, Preschool; Chorea; Consanguinity; Electroencephalography; Female; Glutarates; Humans; Jews; Metabolism, Inborn Errors; Muscle Spasticity; Optic Atrophy; Proteins; Psychomotor Agitation; Seizures; Sleep; Spastic Paraplegia, Hereditary; Status Epilepticus | 2015 |
3-Methylglutaconic aciduria: ten new cases with a possible new phenotype.
Topics: Acidosis; Basal Ganglia Diseases; Child, Preschool; Female; Glutarates; Humans; Infant; Male; Metabolism, Inborn Errors; Nervous System Diseases; Phenotype; Ubiquinone | 1994 |